Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomegranate juice versus sildenafil for intrauterine growth restriction
IRCT20210730052014N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sildenafil in intrauterine growth restriction (IUGR) (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Umbilical artery pulsatility index, Uterine artery pulsatility index and 2 more. Started Sep 2021; status: completed.
02
Drugs
sildenafil
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on IRCT20210730052014N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210730052014N1.